Related Experiment Video
Updated: May 5, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Chronic kidney disease in older people with intellectual disability: results of the HA-ID study
C F de Winter1, M A Echteld2, H M Evenhuis2
1Intellectual Disability Medicine, Erasmus Medical Center Rotterdam, Department of General Practice, Rotterdam, The Netherlands; Reinaerde, Den Dolder, The Netherlands.
Insights
Chronic kidney disease affects 15.3% of older adults with intellectual disability (ID), similar to the general population. Early GFR measurement is recommended for those with ID, especially with sarcopenia or Down syndrome.
Area of Science:
- Gerontology
- Nephrology
- Intellectual Disability Research
Background:
- Aging populations and increased cardiovascular events necessitate understanding chronic kidney disease (CKD) in older adults with intellectual disability (ID).
- Previous research has not fully elucidated CKD prevalence and associated factors in this specific demographic.
Purpose of the Study:
- To determine the prevalence and associations of CKD in individuals aged 50 and over with ID.
- To investigate the impact of sarcopenia on CKD prevalence estimation using different glomerular filtration rate (GFR) equations.
Main Methods:
- Cross-sectional study (Healthy Ageing and Intellectual Disability - HA-ID) of 635 Dutch adults with ID aged 50+.
- Plasma creatinine and cystatin-C measurements to calculate GFR using MDRD and CKD-EPI equations.
- Analysis of CKD prevalence in participants with and without sarcopenia, comparing GFR estimation methods.
Main Results:
- Overall CKD prevalence was 15.3%, comparable to the general Dutch population.
- CKD was associated with older age, Down syndrome, obesity, hypercholesterolemia, and hypothyroid disease.
- In sarcopenic individuals, CKD-EPI (creatinine and cystatin-C) indicated higher prevalence than MDRD, though with wide confidence intervals.
Conclusions:
- CKD prevalence in older adults with ID is similar to the general population.
- Regular GFR monitoring is advised for older adults with ID, particularly those with polypharmacy or Down syndrome.
- For individuals with ID and sarcopenia, GFR assessment should incorporate cystatin-C alongside creatinine to improve accuracy.
Abstract:
With increasing longevity and cardiovascular events, chronic kidney disease may also become a significant problem in older people with intellectual disability (ID). We studied prevalence and associations of chronic kidney disease as part of the Healthy Ageing and Intellectual Disability (HA-ID) study, a large Dutch cross-sectional study among people with ID aged 50 years and over, using creatinine and cystatin-C measurement in plasma. Glomerular filtration rate (GFR) was calculated using the Modification of Diet in Renal Disease (MDRD) and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations. Equations based on creatinine (as the MDRD equation) may underestimate kidney dysfunction in people with sarcopenia, because low muscle mass leads to a low creatinine production. Therefore, also prevalence of chronic kidney disease was studied in the sarcopenic group, using different GFR equations. Prevalence of chronic kidney disease, among 635 participants, was 15.3%, which equals prevalence in the general Dutch population. In the group of participants with sarcopenia (n=82), the CKD-EPI equation based on creatinine and cystatin-C gave a higher prevalence of chronic kidney disease than did the MDRD equation, but confidence intervals were very wide. Chronic kidney disease was associated with higher age, Down syndrome, obesity, hypercholesterolemia and hypothyroid disease. GFR should be measured in all older people with ID and polypharmacy, and in older people with ID and Down syndrome as part of the regular health checks. Moreover, if sarcopenia is present and information on GFR is required, this should not be measured based on creatinine only, but additional measures, such as cystatin-C, should be taken into account.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention

